Jincheng Pharm(300233)2023-10-24 16:00Cash Flow and Financial Activities - The net cash flow from operating activities increased by 121.35% to ¥460,921,031.06 compared to ¥208,227,671.15 in the previous period, primarily due to increased sales collections[10] - The net cash flow from investing activities decreased by 54.79% to -¥157,366,616.95 from -¥348,083,859.42, mainly due to reduced cash payments for the purchase of fixed assets and intangible assets[10] - The net cash flow from financing activities decreased by 194.15% to -¥93,338,975.48 from ¥99,140,461.81, attributed to increased repayment of bank loans and the absence of equity incentive funds received in the same period last year[10] - Total cash and cash equivalents at the end of the period reached ¥1,002,497,766.99, an increase from ¥843,296,253.96 at the end of the previous period[8] - The total cash inflow from operating activities amounted to ¥2,407,494,163.59, compared to ¥2,094,364,322.68 in the previous period[5] - The total cash outflow from operating activities was ¥1,946,573,132.53, compared to ¥1,886,136,651.53 in the previous period[5] - The company received tax refunds totaling ¥37,688,963.68 and other cash related to operating activities amounting to ¥68,852,779.26[5] - The company’s cash outflow for financing activities included dividend payments of ¥80,547,296.91 and other cash payments related to financing activities totaling ¥26,448,993.03[8] - Cash received from sales of goods and services for the current period amounts to 2,300,952,420.65, an increase from 1,989,166,283.19 in the previous period[44] - The cash flow from operating activities shows a positive trend with significant cash inflow compared to the previous period[44] Shareholder Information - The company reported a total of 28,199 common shareholders at the end of the reporting period[11] - The largest shareholder, Zibo Jincheng Investment Co., Ltd., holds 20.35% of the shares, amounting to 78,552,154 shares[11] - The company reported a total share capital reduction of 2,049,840 shares, decreasing from 385,924,427 shares to 383,874,587 shares due to the repurchase and cancellation of restricted stock[19] - The company’s total number of restricted shares at the end of the period was 25,431,264 shares, with various executives holding significant amounts[15] - The company’s executives, including Zhao Hongfu and Zhao Yeqing, are significant shareholders, with Zhao Hongfu holding 7,257,000 restricted shares[15] Stock and Equity Management - The first phase of the employee stock ownership plan was approved, with 62 participants representing 29,452,800 shares, accounting for 100% of the total plan[19] - The company plans to unlock 4,567,749 restricted shares for executive Fu Miaoqing after the expiration of the lock-up period[15] - The company’s total capital will change from RMB 385,924,427 to RMB 383,874,587 following the stock repurchase[19] - The company’s stock ownership plan management committee was established to oversee the employee stock ownership plan[19] Business Operations and Revenue - The company's revenue for Q3 2023 was CNY 863,459,370.88, representing a 16.77% increase year-over-year[30] - Total operating revenue for Q3 2023 was CNY 2,568,752,667.57, a decrease of 0.87% from CNY 2,591,255,169.47 in the same period last year[40] - Operating costs increased to CNY 2,386,749,531.40, up 4.52% from CNY 2,283,411,856.62 year-on-year[40] - The company recorded a net profit of CNY 176,301,377.39, down 46.36% from CNY 328,347,798.15 in the same quarter last year[40] - The net profit attributable to shareholders for Q3 2023 was CNY 30,770,938.85, a decrease of 21.95% compared to the same period last year[30] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 26,972,232.99, down 21.17% year-over-year[30] Assets and Liabilities - The total assets as of September 30, 2023, amounted to CNY 5,945,320,395.12, reflecting a 2.05% increase from the end of the previous year[30] - The total liabilities as of September 30, 2023, were CNY 2,202,549,358.06, compared to CNY 2,166,771,533.90 at the end of the previous year[24] - The company's equity attributable to shareholders was CNY 3,680,271,565.75, an increase of 2.02% from the previous year[30] - The company’s long-term borrowings increased to CNY 398,787,959.47 from CNY 271,690,940.29 in the previous period[24] Research and Development - Research and development expenses increased to CNY 121,823,184.36, up 14.93% from CNY 106,053,338.78 year-on-year[40] - The company is actively investing in new technologies and product development to drive future growth[43] Regulatory and Licensing - The company received a Tobacco Monopoly Production License for electronic cigarette nicotine production, allowing for domestic and export sales, with a production scale not exceeding the limits set by the National Tobacco Monopoly Administration[19] - The company’s subsidiary received an extended production license valid until June 30, 2025, for electronic cigarette nicotine production[19] Income and Expenses - Financial expenses rose by 74.96% to CNY 9,292,512.12, primarily due to a decrease in exchange gains during the reporting period[35] - Investment income showed a significant decline, reporting a loss of CNY 70,366.52 compared to a profit of CNY 3,366,224.35 in the previous year, a decrease of 102.09%[35] - The company reported a significant decrease in non-operating income, which fell by 69.99% to CNY 773,540.77 from CNY 2,577,229.09 in the previous year[38] - Other income rose to CNY 16,589,485.47, an increase of 11.34% from CNY 14,899,154.99 in the previous year[40] Comprehensive Income - The total comprehensive income for the current period is 153,711,697.28, down from 267,089,226.39 in the previous period, indicating a decline of about 42.5%[43] - The net profit attributable to the parent company shareholders for the current period is 132,480,355.98, compared to 258,394,428.98 in the previous period, reflecting a decrease of approximately 48.7%[43] - The basic and diluted earnings per share for the current period are both 0.34, compared to 0.67 in the previous period, representing a decrease of 49.0%[43] - The company reported a decrease in minority shareholders' profit to 14,174,667.20 from 8,694,797.41 in the previous period[43]